148
Journals
668.9K
Articles
12.3M
Citations
108.5K
Authors

Most Cited Articles of Hematology in 2008

TitleJournalYearCitations
Cancer statistics, 2008Ca-A Cancer Journal for Clinicians20088.9K
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesBlood20082.5K
LPS/TLR4 signal transduction pathwayCytokine20081.9K
Improved survival in multiple myeloma and the impact of novel therapiesBlood20081.8K
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphomaBritish Journal of Haematology20081.4K
Human natural killer cellsBlood20081.3K
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyCa-A Cancer Journal for Clinicians20081.3K
Development and validation of a predictive model for chemotherapy-associated thrombosisBlood20081.2K
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamideBiology of Blood and Marrow Transplantation20081.2K
CD4 T cells: fates, functions, and faultsBlood20081.1K
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activityBlood2008944
Acute promyelocytic leukemia: from highly fatal to highly curableBlood2008923
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2Blood2008851
Stem cell concepts renew cancer researchBlood2008791
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithmsLeukemia2008780
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic targetAnnals of Oncology2008771
B lymphocytes: how they develop and functionBlood2008701
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophagesCritical Reviews in Oncology/Hematology2008699
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)Haemophilia2008676
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphomaBlood2008676
Red cell membrane: past, present, and futureBlood2008668
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma ProjectBlood2008664
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaLeukemia2008654
Multiple myelomaBlood2008654
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximabAnnals of Oncology2008651